Explore the words cloud of the HEDIMED project. It provides you a very rough idea of what is the project "HEDIMED" about.
The following table provides information about the project.
TAMPEREEN KORKEAKOULUSAATIO SR
|Coordinator Country||Finland [FI]|
|Total cost||11˙992˙338 €|
|EC max contribution||11˙992˙338 € (100%)|
1. H2020-EU.3.1.2. (Preventing disease)
|Duration (year-month-day)||from 2020-01-01 to 2024-12-31|
Take a look of project's partnership.
|1||TAMPEREEN KORKEAKOULUSAATIO SR||FI (TAMPERE)||coordinator||1˙562˙782.00|
|2||TURUN YLIOPISTO||FI (Turku)||participant||1˙160˙371.00|
|3||Teknologian tutkimuskeskus VTT Oy||FI (Espoo)||participant||954˙253.00|
|4||UNIVERZITA KARLOVA||CZ (PRAHA 1)||participant||816˙037.00|
|5||LUNDS UNIVERSITET||SE (LUND)||participant||646˙512.00|
|7||BAYLOR COLLEGE OF MEDICINE||US (HOUSTON TX)||participant||596˙872.00|
|8||TERVEYDEN JA HYVINVOINNIN LAITOS||FI (HELSINKI)||participant||586˙925.00|
|9||HELSINGIN YLIOPISTO||FI (HELSINGIN YLIOPISTO)||participant||522˙242.00|
|10||TECHNISCHE UNIVERSITAET GRAZ||AT (GRAZ)||participant||470˙233.00|
|11||SIHTASUTUS TARTU ULIKOOLI KLIINIKUM||EE (TARTU)||participant||467˙550.00|
|12||UNIVERSITA DEGLI STUDI DI SIENA||IT (SIENA)||participant||457˙602.00|
|13||TARTU ULIKOOL||EE (TARTU)||participant||417˙811.00|
|14||PIRKANMAA HOSPITAL DISTRICT||FI (TAMPERE)||participant||414˙205.00|
|15||DEN SELVEJENDE INSTITUTION DANSK BORNEASTMA CENTER||DK (GENTOFTE)||participant||397˙915.00|
|16||CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT||CH (NEUCHATEL)||participant||355˙930.00|
|17||CESKA ZEMEDELSKA UNIVERZITA V PRAZE||CZ (PRAHA)||participant||298˙436.00|
|18||OULUN YLIOPISTO||FI (OULU)||participant||287˙096.00|
|19||GNOMON Informatics SA||EL (Thessaloniki)||participant||279˙858.00|
|20||EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH||DE (BONN)||participant||249˙572.00|
|21||SATELLIO OY||FI (HELSINKI)||participant||219˙351.00|
Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challenge. The reasons to this epidemic are not known, but exposome needs to play an important role since genetic factors cannot explain such a rapid change. In the HEDIMED project altogether 20 academic and industrial partners will join their multidisciplinary and supplementary forces to identify exposomic determinants which are driving this epidemic. The project is based on a combination of data and biological samples from large clinical cohorts constituting the largest clinical resource in this field including 350.000 pregnant women, 28.000 children prospectively followed from birth and 6.600 children from cross-sectional studies. HEDIMED focuses on common chronic IMDs that cause a significant disease burden, including type 1 diabetes, celiac disease, allergies and asthma. Exposomic disease determinants and the underlying biological pathways will be identified by exploratory approach using advanced omics and multiplex technologies combined with cutting–edge datamining technologies. Particular emphasis is paid on early fetal and childhood exposome since the disease process is known to start early. Inclusion of several IMDs makes it possible to identify determinants that are common for many IMDs facilitating the development of widely operating treatments. HEDIMED includes also data and samples from clinical trials that have used exposomice interventions and cell and organ culture models to help the identification of causal associations. HEDIMED will generate an open-access toolbox that offers various kind of data, new technologies, interactions forums, latest information and functional tools for several stakeholders to facilitate the efforts to find ways to control the IMD epidemic. HEDIMED will generate several innovations which can become exploited widely in diagnostic, therapeutic, preventive and health-economical applications. HEDIMED will work together with the other projects (EXPANSE, HEAP, ATHLETE, EQUAL-LIFE, LONGITOOLS, EPHOR, REMEDIA and EXIMIOUS) funded within the Human Exposome programme call H2020 SC1-BHC-2018-2020, in order to achieve collaboration and synergy
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEDIMED" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "HEDIMED" are provided by the European Opendata Portal: CORDIS opendata.
Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and EbolaRead More
European platforM to PromOte Wellbeing and HEalth in the woRkplaceRead More
Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.Read More